Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes.

Ivica GrgurevićNermin SalkicSanda MustapicTomislav BokunKristian PodrugSrecko MarusicDario RahelicTomas MaticViktoria SkurlaIvana Mikolasevic

Published in: Canadian journal of gastroenterology & hepatology (2021)

In a cohort of T2D patients, no liver-related morbidity or mortality occurred during 2 years. Our patients probably have low real prevalence of advanced fibrosis which is likely overestimated by LSM ≥ 9.6 kPa. Liver fibrosis may be safely reassessed in the 2 years interval in noncirrhotic patients with T2D.

Keyphrases

liver fibrosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
risk factors
metabolic syndrome
adipose tissue
patient reported outcomes
skeletal muscle